千红制药跌2.00%，成交额1.44亿元，主力资金净流出2650.12万元

Core Viewpoint - Qianhong Biopharma's stock price has experienced fluctuations, with a year-to-date increase of 44.83% but a recent decline in the last 5, 20, and 60 trading days [1] Company Overview - Qianhong Biopharma, established on April 30, 2003, and listed on February 18, 2011, is located in Changzhou, Jiangsu Province. The company specializes in the research, production, and sales of various pharmaceutical products, including lyophilized powder, small-volume injections, tablets, and active pharmaceutical ingredients [2] - The company's main business revenue composition is 62.97% from formulations and 36.70% from active pharmaceutical ingredients [2] - As of June 30, 2025, the number of shareholders increased by 27.00% to 72,800, while the average circulating shares per person decreased by 22.62% to 12,934 shares [2] Financial Performance - For the first half of 2025, Qianhong Biopharma reported revenue of 862 million yuan, a year-on-year increase of 0.72%, and a net profit attributable to shareholders of 258 million yuan, reflecting a significant year-on-year growth of 41.17% [2] - The company has distributed a total of 1.862 billion yuan in dividends since its A-share listing, with 453 million yuan distributed over the past three years [3] Stock Market Activity - On October 14, 2023, Qianhong Biopharma's stock price fell by 2.00% to 8.81 yuan per share, with a trading volume of 144 million yuan and a turnover rate of 1.71%, resulting in a total market capitalization of 11.275 billion yuan [1] - The stock has appeared on the "Dragon and Tiger List" seven times this year, with the most recent appearance on August 7, 2023, where it recorded a net purchase of 10.2288 million yuan [1]